Clinical Study Site

Baltimore, Maryland 21287

2 studies enrolling now · 4 studies all time

What they study most

C3 Glomerulonephritis, C3 Glomerulopathy, Dense Deposit Disease, Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer, Paroxysmal Nocturnal Hemoglobinuria (PNH)

Studies at this site

• Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer — Recruiting now
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 — Recruiting now
• Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to Eculizumab — Completed
• A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G) — Completed